Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6402 posts found.

WHO says world still unprepared for future pandemics even after COVID-19

May 20, 2022 Medical Communications

An expert panel has said that the world is still not ready for future pandemics, despite having years to prepare …
News

Collaboration to boost access to cancer medicines in low- and middle-income countries

May 20, 2022 Medical Communications

Novartis, Roche, and other pharmaceutical companies have formed a coalition with global cancer organisations in an aim to get more …
News

ANGLE technology could alter how prostate cancer is treated

May 20, 2022 Medical Communications

Researchers from Barts Cancer Institute will use ANGLE’s new technology, Parsortix, to isolate and assess circulating tumour cells as a …
News

Evotec and Sernova collaborate into beta cell replacement therapy for diabetes

May 17, 2022 Medical Communications

Evotec and Sernova have announced an exclusive strategic partnership for iPSC-based beta cell replacement therapy to advance a ‘functional cure’ …
News

Breast cancer ‘metal detector’ recommended to NHS

May 17, 2022 Medical Communications

A recommendation by the government’s health advisers have said that women with invasive breast cancer could be injected with a …
News

60,000 NHS staff believed to suffer pandemic-related PTSD

May 13, 2022 Medical Communications

As many as 60,000 NHS staff are believed to be suffering from post-traumatic stress brought on by the COVID-19 pandemic, …
News

New national guidance addressing sepsis

May 13, 2022 Medical Communications

New guidelines proposing significant changes to the way people with suspected sepsis are treated with antibiotics have been published. The …
News

WHO launches first ever global report on Infection Prevention and Control

May 6, 2022 Medical Communications

A new report from WHO has highlighted the importance of effective IPC programmes, and shown that where good hand hygiene …
News

Open Orphan to begin first-ever COVID-19 challenge trial

May 6, 2022 Medical Communications

Open Orphan has been appointed by an unnamed existing “big pharma” client to host a Phase II field study of …
News

FDA narrows use of J&J vaccine due to blood clot risk

May 6, 2022 Medical Communications

The FDA has limited the use of Johnson & Johnson’s coronavirus vaccine, to adults who cannot, or refuse to get, …
News

AstraZeneca’s heart disease drug meets key endpoints in Phase III

May 6, 2022 Medical Communications

AstraZeneca’s treatment for heart disease has delivered positive high-level results from its Phase III DELIVER trial.Farxiga (dapagliflozin) is already approved …
News

Discharging untested patients to care homes was ‘unlawful’, says high court ruling

April 29, 2022 Medical Communications

The High Court has ruled that government policies on discharging untested patients from hospital to care homes in England, at …
News

Pfizer DMD trial moves forward after FDA lifts hold

April 29, 2022 Medical Communications

Pfizer has announced that it will open the first ever US sites in its Phase III trial study, evaluating its …
News

FDA approval for first drug to treat inherited heart condition

April 29, 2022 Medical Communications

Bristol Myers Squibb has received approval from the FDA for their drug, Camzyos™ (mavacamten), marking the drug as the first …
News

Beijing enforces mass COVID-19 testing and closes neighbourhoods

April 26, 2022 Medical Communications

Beijing is enforcing mass testing and closing down access to neighbourhoods as it seeks to contain a new COVID-19 outbreak. …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025